Prudential Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-34,918
| Closed | -$4.02M | – | 2571 |
|
2024
Q3 | $4.02M | Buy |
34,918
+6,993
| +25% | +$804K | 0.01% | 1082 |
|
2024
Q2 | $2.97M | Buy |
27,925
+10,214
| +58% | +$1.09M | ﹤0.01% | 1180 |
|
2024
Q1 | $1.71M | Sell |
17,711
-7,557
| -30% | -$731K | ﹤0.01% | 1538 |
|
2023
Q4 | $2.55M | Buy |
25,268
+2,633
| +12% | +$266K | ﹤0.01% | 1286 |
|
2023
Q3 | $2.31M | Buy |
22,635
+4,172
| +23% | +$425K | ﹤0.01% | 1282 |
|
2023
Q2 | $1.86M | Buy |
18,463
+5,272
| +40% | +$532K | ﹤0.01% | 1447 |
|
2023
Q1 | $1.11M | Sell |
13,191
-2,818
| -18% | -$238K | ﹤0.01% | 1687 |
|
2022
Q4 | $1.45M | Buy |
16,009
+5,449
| +52% | +$494K | ﹤0.01% | 1499 |
|
2022
Q3 | $808K | Buy |
10,560
+1,126
| +12% | +$86.2K | ﹤0.01% | 1859 |
|
2022
Q2 | $800K | Sell |
9,434
-866
| -8% | -$73.4K | ﹤0.01% | 1912 |
|
2022
Q1 | $904K | Buy |
10,300
+1,500
| +17% | +$132K | ﹤0.01% | 1923 |
|
2021
Q4 | $736K | Sell |
8,800
-196
| -2% | -$16.4K | ﹤0.01% | 2026 |
|
2021
Q3 | $751K | Sell |
8,996
-491
| -5% | -$41K | ﹤0.01% | 1962 |
|
2021
Q2 | $866K | Buy |
9,487
+387
| +4% | +$35.3K | ﹤0.01% | 1896 |
|
2021
Q1 | $778K | Buy |
9,100
+1,422
| +19% | +$122K | ﹤0.01% | 1958 |
|
2020
Q4 | $725K | Buy |
7,678
+1,815
| +31% | +$171K | ﹤0.01% | 1905 |
|
2020
Q3 | $510K | Sell |
5,863
-609
| -9% | -$53K | ﹤0.01% | 1950 |
|
2020
Q2 | $565K | Buy |
6,472
+3,208
| +98% | +$280K | ﹤0.01% | 1877 |
|
2020
Q1 | $269K | Buy |
3,264
+691
| +27% | +$56.9K | ﹤0.01% | 2098 |
|
2019
Q4 | $244K | Buy |
+2,573
| New | +$244K | ﹤0.01% | 2272 |
|